SINGAPORE (Jan 8): Rowsley’s announcement in July last year that it would morph into a healthcare company has kept its stock trading heavily — and at rather rich valuations — for several months.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply